Thromb Haemost 2008; 100(04): 527-529
DOI: 10.1160/TH08-07-0497
Theme Issue Editorial
Schattauer GmbH

Vitamin K-dependent proteins: Functions in blood coagulation and beyond

Omar Benzakour
1   Institut de Physiologie et Biologie Cellulaires, CNRS-UMR 6187, Université de Poitiers, Poitiers Cedex, France
› Author Affiliations
Financial support: Our laboratory is supported by grants from La Ligue Nationale Contre le Cancer-Poitou-Charentes and Retina France.
Further Information

Publication History

Received 31 July 2008

Accepted 18 August 2008

Publication Date:
22 November 2017 (online)

 

 
  • References

  • 1 Cranenburg EC, Schurgers LJ, Vermeer C. Vitamin K: the coagulation vitamin that became omnipotent. Thromb Haemost 2007; 98: 120-125.
  • 2 Mann KG, Nesheim ME, Church WR. et al. Surface-dependent reactions of the vitamin K-dependent enzyme complexes. Blood 1990; 76: 1-16.
  • 3 Wallin R, Hutson SM. Warfarin and the vitamin K-dependent gamma-carboxylation system. Trends Mol Med 2004; 10: 299-302.
  • 4 Shearer MJ, Newman P. Metabolism and cell biology of vitamin K. Thromb Haemost 2008; 100: 530-547.
  • 5 Locke D, Koreen IV, Harris AL. Isoelectric points and post-translational modifications of connexin26 and connexin32. FA SEB J 2006; 08: 1221-1223.
  • 6 Vasse M. Protein Z, a protein seeking a pathology. Thromb Haemost 2008; 100: 548-556.
  • 7 Hedner U. Factor VIIa and its potential therapeutic use in bleeding-associated pathologies. Thromb Haemost 2008; 100: 557-562.
  • 8 Monahan P. Factor IX: Insights from knock-out and genetically engineered mice. Thromb Haemost 2008; 100: 563-575.
  • 9 Martorell L, Martínez-González J, Rodríguez C. et al. Thrombin and protease-activated receptors (PARs) in atherothrombosis. Thromb Haemost 2008; 99: 305-315.
  • 10 Sokolova E, Reiser G. Prothrombin/thrombin and the thrombin receptors PA R-1 and PA R-4 in the brain: Localization, expression and participation in neurodegenerative diseases. ThrombHaemost 2008; 100: 576-581.
  • 11 Toltl LJ, Swystun LL, Pepler L. et al. Protective effects of activated protein C in sepsis. THromb Haemost 2008; 100: 582-592.
  • 12 Schurgers L, Cranenburg ECM, Vermeer C. Matrix Gla-protein: The calcification inhibitor in need of vitamin K. Thromb Haemost 2008; 100: 593-603.
  • 13 Hafizi S, Dahlback B. Signalling and functional diversity within the Axl subfamily of receptor tyrosine kinases. Cytokine Growth Factor Rev 2006; 17: 295-304.
  • 14 Lemke G, Rothlin CV. Immunobiology of the TAM receptors. Nat Rev Immunol 2008; 08: 327-336.
  • 15 Clauser S, Peyrard S, Gaussem P. et al. Development of a novel immunoassay for the assessment of plasma Gas6 concentrations and their variation with hormonal status. Clin Chem 2007; 53: 1808-1813.
  • 16 Fernández-Fernández L, Bellido-Martin L, García de Frutos P. Growth arrest-specific gene 6 (GAS6)An outline of its role in haemostasis and inflammation. Thromb Haemost 2008; 100: 604-610.
  • 17 Lu Q, Lemke G. Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Science 2001; 293: 306-311.
  • 18 Scott RS, McMahon EJ, Pop SM. et al. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 2001; 41: 207-211.
  • 19 Lu Q, Gore M, Zhang Q. et al. Tyro-3 family receptors are essential regulators of mammalian spermatogenesis. Nature 1999; 398: 723-728.
  • 20 Prieto AL, Weber JL, Tracy S. et al. Gas6, a ligand for the receptor protein-tyrosine kinase Ty ro-3, is widely expressed in the central nervous system. Brain Res 1999; 816: 646-661.
  • 21 Romero EE, Velazquez-Estades LJ, Deo R. et al. Cloning of rat vitamin K-dependent gamma-glutamyl carboxylase and developmentally regulated gene expression in postimplantation embryos. Exp Cell Res 1998; 243: 334-346.
  • 22 Hall MO, Obin MS, Heeb MJ. et al. Both protein S and Gas6 stimulate outer segment phagocytosis by cultured rat retinal pigment epithelial cells. Exp Eye Res 2005; 08: 581-591.
  • 23 Nakamura YS, Hakeda Y, Takakura N, et al. Tyro 3 receptor tyrosine kinase and its ligand, Gas6, stimulate the function of osteoclasts. Stem Cells 1998; 16: 229-238.
  • 24 Pierre-Jacques H, Glueck CJ, Mont MA. et al. Familial heterozygous protein-S deficiency in a patient who had multifocal osteonecrosis. A case report. J Bone Joint Surg Am 1997; 79: 1079-1084.
  • 25 Ravichandran KS. Recruitment signals from apoptotic cells: invitation to a quiet meal. Cell 2003; 113: 817-820.
  • 26 Cohen PL, Caricchio R, Abraham V. et al. Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J Exp Med 2002; 196: 135-140.
  • 27 Hanayama R, Tanaka M, Miyasaka K, et al. Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science 2004; 304: 1147-1150.
  • 28 Nakano T, Ishimoto Y, Kishino J. et al. Cell adhesion to phosphatidylserine mediated by a product of growth arrest-specific gene 6. J Biol Chem 1997; 272: 29411-29414.
  • 29 Anderson HA, Maylock CA, Williams JA. et al. Serum-derived protein S binds to phosphatidylserine and stimulates the phagocytosis of apoptotic cells. Nat Immunol 2003; 04: 87-91.
  • 30 Todt JC, Hu B, Curtis JL. The receptor tyrosine kinase MerTK activates phospholipase C gamma2 during recognition of apoptotic thymocytes by murine macrophages. J Leukoc Biol 2004; 75: 705-713.